Back

Association between liver fibrosis and atrial fibrillation: a prospective cohort study and mediation analysis

31 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Miscellaneous on atrial fibrillation Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Zhiwei Zeng

Beijing (China)

3 More presentations in this session

Presentation thumbnail
History of bleeding is associated with higher risk of cardiovascular outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry phase III
Doctor B. Corica (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Sex-specific analysis of atrial fibrillation in developing nations
Doctor F. Almanzar Dihmes (Santo Domingo, DO)
Abstract Slides Video
Presentation thumbnail
Meta-analysis of the safety of outpatient sotalol initiation in clinical practice
Doctor M. Shelig (Huntington, US)
Abstract Slides Video

Access the full session

Session thumbnail
Miscellaneous on atrial fibrillation

The Event

Event poster

ESC Congress 2025

31 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
A direct comparison of non-invasive blood markers of liver fibrosis as associates of cardiovascular risk. The Athens cardiometabolic registry
thumbnail
Congress Presentation
Role of liver disease in management and outcomes of european and asian patients with atrial fibrillation: a report from two regional prospective observational AF registries
thumbnail
Congress Presentation
Non-alcoholic fatty liver disease in patients with atrial fibrillation: a report from a global federated health network.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources